Quantitative Investment Management, LLC Ionis Pharmaceuticals Inc Transaction History

Quantitative Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $343,016 - $469,239	-9,931 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $372,132 - $558,330	-8,754 Reduced 46.85%	9,931 $446,000
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $846,430 - $1.13 Million	18,685 New	18,685 $1.06 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $1.94 Million - $2.95 Million	-46,546 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $2.51 Million - $3.04 Million	46,546 New	46,546 $2.81 Million
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $8.16 Million - $9.97 Million	-138,126 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $5 Million - $6.93 Million	80,487 Added 139.64%	138,126 $8.88 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $2.74 Million - $4.2 Million	51,739 Added 876.93%	57,639 $4.68 Million
Q4 2018 Feb 12, 2019	SELL	$43.37 - $59.54 $533,451 - $732,342	-12,300 Reduced 67.58%	5,900 $318,000
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $780,416 - $977,340	18,200 New	18,200 $938,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.